Norepinephrine Reuptake Inhibitor
- Name
- Norepinephrine Reuptake Inhibitor
- Accession Number
- DBCAT003318
- Description
Not Available
- Drugs
Drug Drug Description Atomoxetine A selective norepinephrine reuptake inhibitor (SNRI) used in the management of Attention Deficit Hyperactivity Disorder (ADHD). Solriamfetol Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744]. Viloxazine A selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children. - Drugs & Drug Targets